As imaging volume increases, breast imagers must adapt
August 8, 2025
Radiology faces an inflection point. Can systemic solutions, including AI, prioritize both patient outcomes and radiologist well-being?
Overcoming Challenges with Transpara
In addition to extensive clinical research published in peer reviewed journals, we are always excited to share insights gathered along the path of rigorous scientific study and clinical practice.
Radiology faces an inflection point. Can systemic solutions, including AI, prioritize both patient outcomes and radiologist well-being?
New research suggests Transpara can be used to spot missed cancers
Radiologists can improve their breast cancer detection accuracy with Transpara, according to new research in Radiology
© 2025, ScreenPoint Medical BV. All rights reserved. Transpara® is a registered trademark of ScreenPoint Medical BV. Reproduction of any material contained herein in any format or media without express written permission of ScreenPoint Medical BV is prohibited. *Disclaimer: Transpara is CE marked and FDA cleared for 2D and 3D mammography. CE (0344) certified. FDA 510(k) K241831 and K232096. Not all features are available in all countries. Please check with local representatives.
Lake Medical Imaging Case Study
Download the study to see how Transpara reduces radiologist workload and improves diagnostic confidence.